Stand: 13 June 2023 About three million people in the European Union are affected by cancer. For 1.34 million of them, the disease is fatal. However, around 40 percent of cancer cases could be prevented

Now the DFG is funding the work of the Hannover scientists for another three years with more than 1.6 million euros. ECMO support is not a permanent solution Research is being conducted at the MHH on

in a completely different patient group, namely patients with left ventricular assist devices. (Fig. 1-3) Acute treatment of stroke Acute stroke therapy has made considerable progress in recent years. Many

Renner takes over the management of the clinic (appointed by the University of Basel, actually the "1st generation of the MHH" due to the short time of Prof. Notter's activity), radiotherapy is given its

from 2013 to 2022, Johannes Beller, Julia Graßhoff, Batoul Safieddine, doi: 10.1007/s10389-023-02090-1 . This study analyzed differential trends in long sitting times in Europe between 2013 and 2022 using

Diagnostic and Interventional Radiology Director: Prof. Dr. med. F. Wacker OE 8220 Carl-Neuberg Str. 1 30625 Hanover radiologie @ mh-hannover.de Office Office of Prof. Wacker Mrs. Osterloh Contact Phone:

Address Hannover Medical School Institute ofGeneral Medicine and Palliative Medicine Carl-Neuberg-Strasse 1 30625 Hanover

Hannover. "Kanne" - Campus Bistro : For a quick snack, the Kanne Campus Bistro is located in building I1 on the first floor. It offers a selection of snacks and drinks, ideal for students who need a quick

and attack cancer cells. Various methods are used, such as immune checkpoint inhibitors. "The TOPAZ-1 study shows improvements in overall survival by adding the immune checkpoint inhibitor durvalumab to

Prof. Dr. med. Georg Berding Department of Nuclear Medicine Hannover Medical School Carl-Neuberg-Str. 1 D-30625 Hannover Tel.: + 49 511 532 5598 Fax: + 49 511 532 8588 e-mail: berding.georg@mh-hannover.de